Dr Reddy’s Labs launches osteoporosis drug in the US

Dr Reddy’s Laboratories Ltd said it launched raloxifene hydrochloride tablets –used to treat osteoporosis — in the US market.

Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use.

Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break.

Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause.

The Evista brand and generic had US sales of approximately $265 million MAT for the most recent twelve months ending in September 2016 according to IMS Health.

Dr. Reddy’s Raloxifene tablets are available in 60 mg in bottle count sizes of 30, 100 and 1,000.

Evista is a registered trademark of Eli Lilly and Company.

The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and pharmaceutical drugs, vaccines, biopharmaceuticals etc.

Dr. Reddy’s Laboratories Ltd. is an India pharmaceutical company and offers products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.



TRUMP THREAT: TCS not worried, says we’re not the villains source: NasscomTata Consultancy Services, the largest Indian-owned outsourcing company, said it is able to manage with 75% less new visas this year as it has changed its business and recruitment models in recent years. It also said that outsourcing was key to protecting US jobs, and is not the villain as portrayed.The statement from Rajesh Gopinatha...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been terminated.The total investment will be euro 16.875 million, which comes to about...
Trump shoots back at China over protests on his Taiwan phone call US President Elect Donald Trump shot back at China over the Asian nation's protests over his phone call with the Taiwanese head of state, asking if China was always so particular about keeping US interests in mind when conducting its international policy."Did China ask us if it was OK to devalue their currency (making it hard for our companies to compete...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS primarily develops, manufactures and markets products across various therapeuti...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta tablets of Boehringer Ingelheim Pharmaceuticals, Inc.An Abbreviated New Drug ...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The product is currently marketed in 33 countries, including 21 European Union coun...
Uflex launches pouch to extend shelf life for ghee FMCG company Uflex said it launched new pouche for liquids like ghee or clarified butter for long shelf life.The pouch with sonically sealed spout has been offered to Paras Dairy for packing it's ghee.Uflex, founded in 1983, is India’s largest end-to-end flexible packaging company.Jeevaraj Pillai, Joint President, Packaging and New Product Develo...
Nikon launches DSLR D5600 camera Nikon India said it launched a new DSLR camera --Nikon D5600.The DX-format D-SLR is equipped with a vari-angle LCD monitor that flips out and rotates, touch screen operation enhanced with crop function for use use in playback zoom, frame advance bar for users to scroll through images in playback mode easily, time-lapse movie function, etc.The camera ...
Apprehensions on Trump to prove wrong: ASSOCHAM Industry body ASSOCHAM today expressed confidence that apprehensions linked to President Elect Donald Trump of United States "would certainly prove wrong" in the coming days.The industry association said Trump's sober, very fair sounding and statesman like demeanor promising a fair deal with the rest of the world should indicate an opportunity to take In...
Angry Bernie Sanders’ supporters say “We told you so!” on Trump election Even as many Bernie Sanders' supporters expressed disappointment, and even alarm, at the election of Donald J Trump as the next president of the USA, at least some of them felt vindicated by the results of the election.Sanders, a senator from Vermont, ran on a left-of-center, idealistic platform opposing the 'establishment' and nearly took the De...
India gold price jumps Rs 796 for 10 grams Expect the unexpected is the case what we see in gold price today.The country saw a sudden hike in the gold price today as Rs 30,820 for 10 grams from yesterdays price of Rs 30,024.The price for 10 grams has rose by 796 rupees from yesterday in India.UPDATE: As of 1517 IST, the price of gold on MCX has fallen to 30,384, after touching a high of 3...
Mylan and Biocon submits breast cancer drug application to USFDA Mylan N.V. and Biocon Ltd. said they submitted Mylan’s biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration.Biosimilar trastuzumab is a proposed biosimilar to branded Trastuzumab, which is indicated to treat certain HER2-positive breast and gastric cancers.HER2-positive breast cancer is a breas...
Ambrane launches ´BT-5000´ bluetooth speaker @ Rs 1499 IT brand Ambrane India said it launched a new bluetooth speaker BT5000, priced at just Rs 1499.Ambrane is one of the leading IT brands in computer peripherals, Mobile Accessories and No. 1 in Power Banks.The speaker has in-built Magnetic trumpet that improves the quality of perceptible audio output giving the user a loud and crystal clear sound, the...
OnMobile launches new consumer brand ONMO OnMobile Global Limited launched its new consumer brand, ONMO, and showcased some of its other new products. “The company has been working towards this change for over two years now. It has made significant investments in core technology, product development, processes and people to get ready to serve consumers directly,” said the company.Onmobile ...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being developed to commercialize in Indian and international markets.A serotype is a...